Minimally invasive spine surgery technology in China has developed rapidly in recent years. According to statistics from the National Health Commission, the number of minimally invasive spine surgeries in China exceeded 500,000 cases in 2023, with an annual growth rate of 20%. Among these, transforaminal endoscopic techniques account for over 60%, and robot-assisted surgeries have seen a year-on-year increase of 150%. Multiple top-tier hospitals in Shanghai have routinely adopted Unilateral Biportal Endoscopy (UBE) technology, reducing the average postoperative hospital stay to 2-3 days, a reduction of over 50% compared to traditional open surgery, with complication rates dropping below 2%.
Taking Shanghai Partner Hospitals as an example, Huashan Hospital affiliated with Fudan University completed over 3,000 minimally invasive spine surgeries in 2024, where patients with lumbar disc herniation were able to walk on the same day after surgery, and the discharge rate within 3 days reached as high as 90%. Peking University Third Hospital has taken the lead in introducing the O-arm navigation system, combined with intraoperative CT real-time imaging, improving the accuracy of screw placement to 98.5%.
Background and Significance
The rapid development of minimally invasive spine surgery in China is attributed to technological advancements and policy support. In 2019, the National Health Commission included spinal minimally invasive techniques in the key monitoring targets of the "National Medical Service and Quality Safety Report," promoting the standardization of these techniques. Meanwhile, domestically produced surgical robots, such as Tianji and Hehua, have been approved for market release, reducing costs by 30% compared to imported equipment and accelerating the dissemination of technology. According to a 2024 review in the Chinese Journal of Orthopaedics, minimally invasive spine surgery in China has transitioned from the era of "discoscopy" to a stage of "intelligent and precise" development, particularly in areas such as degenerative lumbar diseases and spinal fractures, where outcomes are comparable to open surgery but with less trauma and faster recovery.
Significance for International Patients
For overseas patients, minimally invasive spine technology in China offers a cost-effective option. For example, the average cost of lumbar fusion surgery in the United States is approximately $50,000 to $100,000, with a hospital stay of 5-7 days, whereas the same surgery in China costs only $10,000 to $20,000, with a hospital stay of 2-3 days. Additionally, Chinese hospitals adhere to international quality control standards, with some centers holding JCI accreditation, and many surgeons have overseas training backgrounds. International patients can also benefit from advanced minimally invasive techniques, such as UBE and OLIF (Oblique Lateral Interbody Fusion), which reduce muscle damage and preserve spinal stability, making them particularly suitable for elderly patients or those with underlying comorbidities.
How MedBridge Helps
MedBridge Shanghai, as a cross-border medical platform, connects international patients with top minimally invasive spine experts in China, providing comprehensive support for medical services. Based on patient medical records, we utilize the cost estimator tool to ensure transparent medical expenses, and assist with medical visa applications, medical record translation, appointment scheduling, and hospitalization. During treatment, MedBridge coordinates bilingual medical consultants to ensure seamless communication between doctors and patients, and provides postoperative rehabilitation guidance. Through contact us, patients can obtain personalized diagnosis and treatment plans, including telemedicine consultation services, to assess surgical feasibility in advance. MedBridge has served patients from 46 countries with a satisfaction rate of 98%, committed to enabling global patients to benefit from China's minimally invasive technology.
Related reading: Overview of Shanghai Partner Hospitals